MAPT and Alzheimer disease: In addition to the proteins associated with amyloid pathology, our EV proteome analysis revealed proteins with unknown pathophysiological functions whose expression is altered in tau pathology/neurodegeneration, which may lead to the elucidation of the molecular pathogenesis of AD and the development of new therapeutic agents.